APA aipamena

Jung, J. H., You, S., Oh, J. W., Yoon, J., Yeon, A., Shahid, M., . . . Kim, J. (2018). Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target. Cancer Lett.

Chicago Style aipamena

Jung, Jae Hun, et al. "Integrated Proteomic and Phosphoproteomic Analyses of Cisplatin-sensitive and Resistant Bladder Cancer Cells Reveal CDK2 Network As a Key Therapeutic Target." Cancer Lett 2018.

MLA aipamena

Jung, Jae Hun, et al. "Integrated Proteomic and Phosphoproteomic Analyses of Cisplatin-sensitive and Resistant Bladder Cancer Cells Reveal CDK2 Network As a Key Therapeutic Target." Cancer Lett 2018.